SEPTInvestingStart Free

INO 8-K: Secondary offering

Inovio Pharmaceuticals

Filed with the SEC on · accession 0001193125-26-452658

INO filed a 8-K (current report) with the SEC on Nov 9, 2026. Inovio Pharmaceuticals entered into an underwriting agreement for a public offering of 58,747,235 shares of common stock at $1.05 per share and pre-funded warrants to purchase up to 12,681,337 shares at $1.049 per warrant.

Summary of the filing

Inovio Pharmaceuticals entered into an underwriting agreement for a public offering of 58,747,235 shares of common stock at $1.05 per share and pre-funded warrants to purchase up to 12,681,337 shares at $1.049 per warrant. The underwriters fully exercised their option for 10,714,285 additional shares, bringing expected net proceeds to approximately $80.5 million.

For details, click here →How to read a 8-K →

Key details

Shares of common stock offeredshares 58.7M
Public offering price per share$1
Pre-funded warrants offeredwarrants 12.7M
Public offering price per pre-funded warrant$1
Additional shares from underwriters' option exerciseshares 10.7M
Expected net proceeds$80.5M
IssuerInovio Pharmaceuticals, Inc.
Underwriter representativeJefferies LLC
Underwriter representativePiper Sandler & Co.
Legal counselCooley LLP

✦ Ask GOAX AI about this filing — what it means for INO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for INO?

Click here

Frequently asked questions

What did INO file with the SEC on Nov 9, 2026?

INO filed a 8-K (Secondary offering). Inovio Pharmaceuticals entered into an underwriting agreement for a public offering of 58,747,235 shares of common stock at $1.05 per share and pre-funded warrants to purchase up to 12,681,337 shares at $1.049 per warrant. The underwriters fully exercised their option for 10,714,285 additional shares, bringing expected net proceeds to approximately $80.5 million.

What does a secondary offering mean for INO stock?

New shares dilute existing holders and are often sold at a discount to the market price.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other INO SEC filings

Get alerts when INO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
INO overviewINO analysisINO newsLatest SEC filings